JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
J Neurovirol
; 21(6): 645-52, 2015 Dec.
Article
in En
| MEDLINE
| ID: mdl-25052191
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA, Viral
/
Multiple Sclerosis, Relapsing-Remitting
/
Natalizumab
/
Immunologic Factors
/
Antibodies, Viral
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Neurovirol
Journal subject:
NEUROLOGIA
/
VIROLOGIA
Year:
2015
Type:
Article
Affiliation country:
Italy